AU1566199A - Use in a pharmaceutical composition to be administered through the nose of hydrophilic particles for delivering active agents to the central nervous system - Google Patents

Use in a pharmaceutical composition to be administered through the nose of hydrophilic particles for delivering active agents to the central nervous system

Info

Publication number: AU1566199A
Authority: AU; Australia
Prior art keywords: nose; administered; pharmaceutical composition; nervous system; active agents
Prior art date: 1997-12-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU15661/99A

Inventor

Didier Betbeder

Sandrine Sperandio

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Biovector Therapeutics SA

Original Assignee

Biovector Therapeutics SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-09

Filing date

1998-12-09

Publication date

1999-06-28

1998-12-09 Application filed by Biovector Therapeutics SA filed Critical Biovector Therapeutics SA

1999-06-28 Publication of AU1566199A publication Critical patent/AU1566199A/en

Status Abandoned legal-status Critical Current

Links

239000013543 active substance Substances 0.000 title 1
210000003169 central nervous system Anatomy 0.000 title 1
239000002245 particle Substances 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Optics & Photonics (AREA)
Nanotechnology (AREA)
Physics & Mathematics (AREA)
Otolaryngology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU15661/99A 1997-12-09 1998-12-09 Use in a pharmaceutical composition to be administered through the nose of hydrophilic particles for delivering active agents to the central nervous system Abandoned AU1566199A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9715565A FR2771929B1 (en)	1997-12-09	1997-12-09	USE IN A PHARMACEUTICAL COMPOSITION FOR THE NASAL DELIVERY OF HYDROPHILIC PARTICLES FOR THE DELIVERY OF ACTIVE AGENTS TO THE CENTRAL NERVOUS SYSTEM
FR9715565		1997-12-09
PCT/FR1998/002674 WO1999029295A1 (en)	1997-12-09	1998-12-09	Use in a pharmaceutical composition to be administered through the nose of hydrophilic particles for delivering active agents to the central nervous system

Publications (1)

Publication Number	Publication Date
AU1566199A true AU1566199A (en)	1999-06-28

Family

ID=9514365

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU15661/99A Abandoned AU1566199A (en)	1997-12-09	1998-12-09	Use in a pharmaceutical composition to be administered through the nose of hydrophilic particles for delivering active agents to the central nervous system

Country Status (3)

Country	Link
AU (1)	AU1566199A (en)
FR (1)	FR2771929B1 (en)
WO (1)	WO1999029295A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10004547A1 (en) *	2000-02-02	2001-08-09	Liedtke Pharmed Gmbh	Selective delivery of drugs to the central nervous system, e.g. for treatment of stress or depression, by administration to the olfactory region in doses inducing central nervous system action

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE156704T1 (en) *	1989-12-05	1997-08-15	Ramsey Foundation	NEUROLOGICAL AGENTS FOR NASAL ADMINISTRATION TO THE BRAIN
GB9202464D0 (en) *	1992-02-05	1992-03-18	Danbiosyst Uk	Composition for nasal administration
FR2704145B1 (en) *	1993-04-21	1995-07-21	Pasteur Institut	Particulate vector and pharmaceutical composition containing it.
GB9310412D0 (en) *	1993-05-20	1993-07-07	Danbiosyst Uk	Nasal nicotine system
CA2184242C (en) *	1994-02-28	2000-05-02	Jorg Kreuter	Drug targeting system, method for preparing same and its use
AU6003896A (en) *	1995-06-08	1997-01-09	Janssen Pharmaceutica N.V.	Starch microsphere anti migraine composition
US6096291A (en) *	1996-12-27	2000-08-01	Biovector Therapeutics, S.A.	Mucosal administration of substances to mammals

1997
- 1997-12-09 FR FR9715565A patent/FR2771929B1/en not_active Expired - Fee Related
1998
- 1998-12-09 WO PCT/FR1998/002674 patent/WO1999029295A1/en active Application Filing
- 1998-12-09 AU AU15661/99A patent/AU1566199A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO1999029295A1 (en)	1999-06-17
FR2771929A1 (en)	1999-06-11
FR2771929B1 (en)	2001-02-23

Similar Documents

Publication	Publication Date	Title
CA2264852A1 (en)	1998-04-09	Use of methylphenidate or a pharmaceutically acceptable salt thereof
EP0783299A4 (en)	1999-06-30	Compounds and compositions for delivering active agents
EP0513702A3 (en)	1992-11-25	Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
NZ517659A (en)	2004-12-24	Pharmaceutical delivery system for enhanced absorption of hydrophilic therapeutic agents
ITMI931486A0 (en)	1993-07-09	PHARMACEUTICAL FORMS INTENDED FOR ORAL ADMINISTRATION ABLE TO RELEASE ACTIVE SUBSTANCES AT CONTROLLED AND DIFFERENTIATED RATE
AU6675198A (en)	1998-09-18	Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
CA2345121A1 (en)	2000-03-30	Pharmaceutical composition for the treatment of acute disorders
ZA964735B (en)	1996-12-19	Compositions and methods for topical administration of pharmaceutically active agents
AU4066693A (en)	1994-07-19	Compacted drug body for use in the mechanical generation of inhalable active-substance particles
ZA95743B (en)	1995-08-01	Therapeutic agents
IL131163A (en)	2005-06-19	Heteroaryl-hexanoic acid amide derivatives, their use in the preparation of medicaments, and pharmaceutical compositions comprising them
IE890921L (en)	1989-09-29	Pharmaceutical composition for systemic transdermal administration
IL127572A (en)	2003-04-10	Pharmaceutical composition and medicament for nasal administration
AU2049500A (en)	2000-06-26	Administration of neurotrophic agents to the central nervous system
AU9018898A (en)	1999-03-08	Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
MY111260A (en)	1999-10-30	Pharmaceutical composition for the treatment of nicotine dependence
HUP0302333A3 (en)	2005-07-28	The use of glatiramer acetate (copolymer 1) for the preparation of pharmaceutical compositions available in the treatment of central nervous system disorders
UA66812C2 (en)	2004-06-15	Drug formulation with controlled release of active ingredient
AU5088993A (en)	1994-03-15	Cocaine analogues and their use as ***e drug therapies and therapeutic and imaging agents for neurodegenerative disorders
GB9700817D0 (en)	1997-03-05	Drug delivery composition for the nasal administration of antiviral agents
AU3986097A (en)	1998-03-19	Lipophilic polyamine esters for the site specific delivery of nitric oxide in pharmaceutical use
EP0393707A3 (en)	1992-03-18	Bioactive compounds associated with liposomes and their use in pharmaceutical preparations
AU5650894A (en)	1994-07-04	Tachyquinine antagonists, their preparation and use in pharmaceutical formulations
PL348202A1 (en)	2002-05-06	Pharmaceutically active composition and dispensing device
AU1566199A (en)	1999-06-28	Use in a pharmaceutical composition to be administered through the nose of hydrophilic particles for delivering active agents to the central nervous system

Legal Events

Date	Code	Title	Description
2000-08-24	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase